NASTAD Announces 2019-2020 Board of Directors

By Kyle Taylor June 3, 2019

NASTAD Announces 2019-2020 Board of Directors

Washington, DC - Last week, NASTAD, a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world, announced its 2019-2020 Board of Directors. NASTAD is governed by a 23-member, elected Board charged with making policy and program decisions on behalf of the full membership.

The 2019-2020 Board of Directors includes:

Officers (Executive Committee)
Johanne Morne, New York, Chair
Marlene McNeese, Houston, Chair-Elect
John Sapero, Arizona, Vice-Chair
Michael Kharfen, District of Columbia, Secretary-Treasurer 
Jacquelyn Clymore, North Carolina, Immediate Past-Chair (ex-officio, voting)
Terrance Moore, Acting Exectuive Director (ex-officio, non-voting)
 
Board Members
Sharon Jordan, Alabama
Susan Jones, Alaska
Dave Kern, Chicago
Laura Reeves, Florida
William Lyons, Georgia
Peter Whiticar, Hawaii
Randy Mayer, Iowa
Dawn Fukuda, Massachusetts
Kendra Johnson, Mississippi
Andrew Gans, New Mexico
Demetre Daskalakis, New York City
Thomas Bertrand, Rhode Island
Tracey Packer, San Francisco
Ali Mansaray, South Carolina
Shelley Lucas, Texas
Hadiyah Charles, U.S. Virgin Islands
Beth Crutsinger-Perry, Washington
 

“It is my pleasure to welcome the 2019-2020 Board of Directors,” said Terrance Moore, NASTAD Acting Executive Director. “I look forward to a productive and eventful year as we work together under the guidance of our Board Chair, Johanne Morne, and her Chair’s Challenge:The Time is NOW: End the Epidemics. This year, we are calling on our members to launch or expand jurisdictional Ending the Epidemic plans, sign on to Undetectable = Untransmittable, and expand PrEP in their jurisdictions.” 

About NASTAD

Founded in 1992, NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world. Our singular mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions. We do this work by strengthening domestic and global governmental public health through advocacy, capacity building, and social justice.

###